These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

423 related articles for article (PubMed ID: 9723701)

  • 1. CD4+ T cells inhibit growth of Epstein-Barr virus-transformed B cells through CD95-CD95 ligand-mediated apoptosis.
    Wilson AD; Redchenko I; Williams NA; Morgan AJ
    Int Immunol; 1998 Aug; 10(8):1149-57. PubMed ID: 9723701
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytolytic CD4(+)-T-cell clones reactive to EBNA1 inhibit Epstein-Barr virus-induced B-cell proliferation.
    Nikiforow S; Bottomly K; Miller G; Münz C
    J Virol; 2003 Nov; 77(22):12088-104. PubMed ID: 14581546
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD4+ T-cell clones recognizing human lymphoma-associated antigens: generation by in vitro stimulation with autologous Epstein-Barr virus-transformed B cells.
    Long HM; Zuo J; Leese AM; Gudgeon NH; Jia H; Taylor GS; Rickinson AB
    Blood; 2009 Jul; 114(4):807-15. PubMed ID: 19443664
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Primary CD4+ T-cell responses provide both helper and cytotoxic functions during Epstein-Barr virus infection and transformation of fetal cord blood B cells.
    MacArthur GJ; Wilson AD; Birchall MA; Morgan AJ
    J Virol; 2007 May; 81(9):4766-75. PubMed ID: 17314172
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD4+ T-cell effectors inhibit Epstein-Barr virus-induced B-cell proliferation.
    Nikiforow S; Bottomly K; Miller G
    J Virol; 2001 Apr; 75(8):3740-52. PubMed ID: 11264363
    [TBL] [Abstract][Full Text] [Related]  

  • 6. T cells specific for different latent and lytic viral proteins efficiently control Epstein-Barr virus-transformed B cells.
    Nowakowska J; Stuehler C; Egli A; Battegay M; Rauser G; Bantug GR; Brander C; Hess C; Khanna N
    Cytotherapy; 2015 Sep; 17(9):1280-91. PubMed ID: 26276009
    [TBL] [Abstract][Full Text] [Related]  

  • 7. EBV latency III immortalization program sensitizes B cells to induction of CD95-mediated apoptosis via LMP1: role of NF-kappaB, STAT1, and p53.
    Le Clorennec C; Youlyouz-Marfak I; Adriaenssens E; Coll J; Bornkamm GW; Feuillard J
    Blood; 2006 Mar; 107(5):2070-8. PubMed ID: 16317104
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CD4+ T cell-induced differentiation of EBV-transformed lymphoblastoid cells is associated with diminished recognition by EBV-specific CD8+ cytotoxic T cells.
    Khanolkar A; Fu Z; Underwood LJ; Bondurant KL; Rochford R; Cannon MJ
    J Immunol; 2003 Mar; 170(6):3187-94. PubMed ID: 12626577
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Functional analysis of the CD4(+) T-cell response to Epstein-Barr virus: T-cell-mediated activation of resting B cells and induction of viral BZLF1 expression.
    Fu Z; Cannon MJ
    J Virol; 2000 Jul; 74(14):6675-9. PubMed ID: 10864684
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro cytokine production and growth inhibition of lymphoblastoid cell lines by CD4+ T cells from Epstein-Barr virus (EBV) seropositive donors.
    Wilson AD; Hopkins JC; Morgan AJ
    Clin Exp Immunol; 2001 Oct; 126(1):101-10. PubMed ID: 11678905
    [TBL] [Abstract][Full Text] [Related]  

  • 11. hTERT inhibition triggers Epstein-Barr virus lytic cycle and apoptosis in immortalized and transformed B cells: a basis for new therapies.
    Giunco S; Dolcetti R; Keppel S; Celeghin A; Indraccolo S; Dal Col J; Mastorci K; De Rossi A
    Clin Cancer Res; 2013 Apr; 19(8):2036-47. PubMed ID: 23444223
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Primary immune responses by cord blood CD4(+) T cells and NK cells inhibit Epstein-Barr virus B-cell transformation in vitro.
    Wilson AD; Morgan AJ
    J Virol; 2002 May; 76(10):5071-81. PubMed ID: 11967323
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epstein-Barr virus induces Fas (CD95) in T cells and Fas ligand in B cells leading to T-cell apoptosis.
    Tanner JE; Alfieri C
    Blood; 1999 Nov; 94(10):3439-47. PubMed ID: 10552954
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human purified protein derivative-specific CD4+ T cells use both CD95-dependent and CD95-independent cytolytic mechanisms.
    Lewinsohn DM; Bement TT; Xu J; Lynch DH; Grabstein KH; Reed SG; Alderson MR
    J Immunol; 1998 Mar; 160(5):2374-9. PubMed ID: 9498779
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Absence of Epstein-Barr virus-specific, HLA class II-restricted CD4+ cytotoxic T lymphocytes in infectious mononucleosis.
    Enssle KH; Fleischer B
    Clin Exp Immunol; 1990 Mar; 79(3):409-15. PubMed ID: 1690617
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Signaling by the Epstein-Barr virus LMP1 protein induces potent cytotoxic CD4
    Choi IK; Wang Z; Ke Q; Hong M; Qian Y; Zhao X; Liu Y; Kim HJ; Ritz J; Cantor H; Rajewsky K; Wucherpfennig KW; Zhang B
    Proc Natl Acad Sci U S A; 2018 Jan; 115(4):E686-E695. PubMed ID: 29311309
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CD4+ T-cell induction of Fas-mediated apoptosis in Burkitt's lymphoma B cells.
    Schattner EJ; Mascarenhas J; Bishop J; Yoo DH; Chadburn A; Crow MK; Friedman SM
    Blood; 1996 Aug; 88(4):1375-82. PubMed ID: 8695856
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CD80 (B7.1) and CD86 (B7.2) induce EBV-transformed B cell apoptosis through the Fas/FasL pathway.
    Park GB; Kim YS; Lee HK; Cho DH; Kim D; Hur DY
    Int J Oncol; 2013 Nov; 43(5):1531-40. PubMed ID: 24008628
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Melanoma-specific CD4+ T lymphocytes recognize human melanoma antigens processed and presented by Epstein-Barr virus-transformed B cells.
    Topalian SL; Rivoltini L; Mancini M; Ng J; Hartzman RJ; Rosenberg SA
    Int J Cancer; 1994 Jul; 58(1):69-79. PubMed ID: 7516926
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preferential utilization of the perforin/granzyme pathway for lysis of Epstein-Barr virus-transformed lymphoblastoid cells by virus-specific CD4+ T cells.
    Khanolkar A; Yagita H; Cannon MJ
    Virology; 2001 Aug; 287(1):79-88. PubMed ID: 11504544
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.